News | May 25, 2022
Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic
The approval is for Ibrutinib tablets 560 mg, 420 mg, 280 mg and 140 mg strengths
Subscribe To Our Newsletter & Stay Updated
